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Abstract. 
 
Cartilage provides the template for endo-
chondral ossification and is crucial for determining the 
length and width of the skeleton. Transgenic mice with 
targeted expression of recombinant cartilage-derived 
morphogenetic protein-1 (CDMP-1), a member of the 
bone morphogenetic protein family, were created to in-
vestigate the role of CDMP-1 in skeletal formation. 
The mice exhibited chondrodysplasia with expanded 
cartilage, which consists of the enlarged hypertrophic 
zone and the reduced proliferating chondrocyte zone. 
Histologically, CDMP-1 increased the number of chon-
droprogenitor cells and accelerated chondrocyte differ-
entiation to hypertrophy. Expression of CDMP-1 in the 
notochord inhibited vertebral body formation by block-
ing migration of sclerotome cells to the notochord. 
These results indicate that CDMP-1 antagonizes the 
ventralization signals from the notochord. Our study 
suggests a molecular mechanism by which CDMP-1 
regulates the formation, growth, and differentiation of 
the skeletal elements.
Key words: bone morphogenetic protein family ¥ car-
tilage ¥ ectopic expression ¥ skeletal abnormalities ¥ 
transgenic mice
 
C
 
ARTILAGE
 
 is a highly specialized tissue and serves as
the template for the development of most bones.
Cartilage development is initiated by mesenchy-
mal cell condensation to form primordial cartilage fol-
lowed by chondrocyte maturation processes. These include
resting, proliferative, prehypertrophic, and hypertrophic
chondrocytes. As a final step in endochondral bone forma-
tion, the hypertrophic cartilage is invaded by blood vessels
and osteoprogenitor cells, and the calcified cartilage is
subsequently replaced by bone. Thus, spatial and temporal
regulation of chondrocyte differentiation is essential in de-
termining the length and width of skeletal components.
Bone morphogenetic proteins (BMPs)
 
1
 
 were originally
identified as proteins capable of inducing ectopic en-
dochondral bone formation in subcutaneous implants
(Urist et al., 1979; Sampath and Reddi, 1981). Subsequent
molecular cloning revealed that the BMP family consists
of a large number of related molecules which belong to the
TGF-
 
b
 
 superfamily (Wozney et al., 1988; reviewed in Ho-
gan, 1996). Although BMPs were initially found in the
bone matrix, it is now clear that they are expressed in a va-
riety of tissues each with unique tissue specificity. BMPs
have diverse biological activities including promoting cell
proliferation, differentiation, and apoptosis and regulating
development of various organs and tissue repair (reviewed
in Hogan, 1996). Among the BMP family, Bmp2, Bmp4,
and Bmp7 are expressed in perichondrium (Macias et al.,
1997; Zou et al., 1997) and Bmp6 in hypertrophic chondro-
cytes (Lyons et al., 1989; Vortkamp et al., 1996). All are
thought to play a role in skeletogenesis during develop-
ment. However, the cellular and molecular mechanisms of
their action on cartilage and bone formation are not well
understood.
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1. 
 
Abbreviations used in this paper:
 
 AgNOR, silver stain for nucleolar or-
ganizer regions; BMP, bone morphogenetic protein; CDMP-1, cartilage-
derived morphogenetic protein-1; d.p.c., days postcoitus; GDF5, growth
and differentiation factor 5. 
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Growth and differentiation factor 5 (GDF5) is a rela-
tively new member of the BMP family. Like other BMPs,
implantation of recombinant GDF5 can induce ectopic
cartilage formation in muscular tissues (Htten et al.,
1996). Null mutations of GDF5 reduce the size of skeletal
components in the limb of 
 
brachypodism
 
 (
 
bp
 
) mice (Storm
et al., 1994). The human homologue of GDF5, termed car-
tilage-derived morphogenetic protein-1 (CDMP-1), was
independently identified by degenerate PCR amplification
of mRNA from articular cartilage (Chang et al., 1994).
Mutations of the 
 
CDMP-1
 
 gene have been identified in
patients with acromesomelic chondrodysplasia Hunter-
Thompson type and Grebe type which are characterized
by short limbs, especially the distal part of the limbs and
by the absence of several phalangeal joints (Thomas et al.,
1996, 1997). In addition, autosomal dominant brachydac-
tyly type C is caused by mutation in the 
 
CDMP-1
 
 gene
(Polinkovsky et al., 1997). Expression of GDF5/CDMP-1
is restricted to the primordial cartilage of appendicular
skeleton (Chang et al., 1994; Storm et al., 1994; Storm and
Kingsley, 1996). Little expression of GDF5/CDMP-1 is
found in the axial skeleton such as vertebrae and rib. This
restricted spatial expression pattern of the 
 
Gdf5/CDMP1
 
gene accounts for the unique chondrodysplasia phenotype
with few abnormalities in the axial skeleton in mice and
humans. These results suggest that GDF5/CDMP-1 plays a
crucial role in the patterning of the appendicular skeleton,
longitudinal bone growth, and chondrogenesis.
Cartilage consists of a large extracellular matrix main-
tained by chondrocytes. Type II collagen, the major com-
ponent of cartilage, forms fibrils. Type XI collagen, a mi-
nor collagen, regulates formation of the collagen fibrils.
We previously identified the promoter and first intron en-
hancer sequences responsible for the cartilage- and noto-
chord-specific expression of the 
 
a
 
2 type XI collagen gene
(
 
Col11a2
 
) (Tsumaki et al., 1996; Tsumaki et al., 1998). The
 
a
 
2(XI) collagen promoter is capable of directing expres-
sion in cartilage but not in the notochord. Inclusion of the
first intron in the 
 
a
 
2(XI) promoter significantly enhances
the promoter activity in cartilage and directs expression in
the notochord. An enhancer from the first intron of the
 
a
 
1 type II collagen gene (
 
Col2a1
 
) directs much stronger
chondrocyte-specific expression (Horton et al., 1987; Krebs-
bach et al., 1996).
In this study, we have generated transgenic mice ex-
pressing recombinant CDMP-1 at different levels under
the control of the 
 
a
 
2(XI) or 
 
a
 
1(II) collagen promoter/
enhancer sequences to define the action of CDMP-1 on
endochondral bone formation and skeletal growth. These
transgenic mice died before or just after birth and showed
a chondrodysplasia-like phenotype with expanded primor-
dial cartilage not only in the limb skeleton but also in the
axial skeleton. The remarkable feature of the cartilage of
all of the transgenic mice is the expansion of a hyper-
trophic zone and the reduced height of zones of prolifer-
ative chondrocytes. The transgenic mice also showed
enlarged mesenchymal condensations and increased the
number of prechondrogenic cells. These results suggest
that CDMP-1 promotes differentiation of chondrocytes
into hypertrophy and enhances commitment of mesenchy-
mal cells into the chondrocytic lineage. Interestingly, ex-
pression of CDMP-1 in the notochord before the onset of
chondrogenesis appeared to inhibit the migration of sclero-
tome cells to form primordial cartilage around the noto-
chord, resulting in the absence of the vertebral bodies.
 
Materials and Methods
 
Construction of the Transgene
 
The 
 
a
 
2(XI) collagen geneÐbased expression vectors, 742
 
lacZ
 
 and
742
 
lacZ
 
Int, have been described previously (Tsumaki et al., 1996).
742
 
lacZ
 
 contains the 
 
Col11a2
 
 promoter (
 
2
 
742 to 
 
1
 
380), an SV-40 RNA
splice site, the 
 
b
 
-galactosidase reporter gene, and the SV-40 polyadenyla-
tion signal. 742
 
lacZ
 
Int also contains 2.3 kb of the first intron sequence
downstream of the SV-40 polyadenylation signal as an enhancer. The type
II collagen geneÐbased expression vector was generated by linking 
 
Col2a1
 
promoter (
 
2
 
956 to 
 
1
 
77), the rabbit 
 
b
 
-globin splice site, the 
 
b
 
-galactosi-
dase reporter gene, the SV-40 polyadenylation signal, and the fragment of
 
Col2a1
 
 first intron (
 
1
 
2038 to 
 
1
 
2678). The fragment of the first intron con-
tains tissue-specific enhancer elements (Zhou et al., 1995; Krebsbach et
al., 1996).
A 1.6-kb DNA fragment covering the entire coding region of the hu-
man CDMP-1 cDNA was generated by PCR using a forward primer
tagged with NotI site (AAA TAT GCG GCC GCT CTA GAG TCA
TTC AGC GGC TGG CCA GAG GAT) and a reverse primer with NotI
site (TGT AGA TGC TGC GGC CAC AGC TTC CTG). After digestion
with NotI, the PCR fragment was cloned into the NotI site of 742
 
lacZ-
 
,
742
 
lacZ
 
Int-, and 
 
Col2a1-
 
based expression vectors by replacing the
 
b
 
-galactosidase gene to create three 
 
CDMP1
 
 expression vectors, 742-
 
CDMP1
 
, 742-
 
CDMP1
 
-Int, and 
 
Col2a1-CDMP1
 
,
 
 
 
respectively.
 
Generation of Transgenic Mice
 
The plasmids 742-
 
CDMP1
 
 and 742-
 
CDMP1
 
-Int were digested with NdeI
and HindIII to release the inserts from their vector sequences. The plas-
mid
 
 Col2a1
 
-
 
CDMP1
 
 was digested with BssHII to release the vector se-
quence. Transgenic mice were produced by microinjecting each of the in-
serts into the pronuclei of fertilized eggs from F
 
1
 
 hybrid mice (C57BL/6 
 
3
 
C3H) as described previously (Hogan et al., 1994). Transgenic embryos
were identified by PCR assays of genomic DNA extracted from the pla-
centa or skin. The DNA was subjected to transgene-specific PCR with
primers derived from the human 
 
CDMP-1
 
 cDNA (TGA GGA CAT
GGT CGT CCA GTC GTC TGG) and from the SV-40 poly(A) signal re-
gion (TCA CTG CAT TCT AGT TGT GGT TTG TCC) to amplify an
192-bp product.
 
Staining of Skeleton
 
Cartilage and bones of embryos and newborn mice were stained as de-
scribed (Peters, 1977). After skin and internal organs were removed, sam-
ples were fixed in 96% ethanol for 2 d followed by staining with alcian
blue solution (80 ml ethanol 96%, 20 ml acetic acid, 15 mg alcian blue) for
2 d. The samples were dehydrated in 100% ethanol for 5 d and immersed
in 1% KOH for 2 d. The samples were stained with 0.001% alizarin red S
solution in 1% KOH for 2 d followed by dehydration in graded solutions
of glycerin and stored in 100% glycerin.
 
Histology
 
Embryos were dissected with a stereomicroscope, fixed in 4% paraformal-
dehyde, processed, and embedded in paraffin. Serial sections were pre-
pared and stained with hematoxylin and eosin, safranin O-fast green-iron
hematoxylin. To assess the proliferative activity, silver stain for nucleolar
organizer regions (AgNOR) was performed as previously described
(Crocker and Nar, 1987). Then the numbers of AgNOR dots in 50Ð100
cells were counted. Cryostat sections of dissected tissues embedded in Tis-
sue-Tek OCT compound were stained with hematoxylin and eosin.
 
Hybridization Probes
 
Probes included human 
 
CDMP1
 
 cDNA (an ApaI fragment, residue 470Ð
1155) (Chang et al., 1994) and mouse 
 
a
 
2(XI) collagen cDNA (pRAC2-28)
(Tsumaki and Kimura, 1995). Mouse 
 
Ihh 
 
(Hh-14.1) and 
 
Shh 
 
(Hh-16.1) 
Tsumaki et al. 
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cDNA probes were provided by A. McMahon (Echelard et al., 1993).
Mouse 
 
Pax1
 
 cDNA (a HincII-SacI fragment) was obtained from H. Ko-
seki and R. Balling (Deutsch et al., 1988). Mouse 
 
PTHrP
 
 cDNA (a AvrII/
SmaI fragment) and PTH/PTHrP receptor cDNA (a Sau3A/PvuII frag-
ment) were obtained from A. Broadus (Mangin et al., 1990). Mouse 
 
a
 
1(X)
collagen cDNA (pRK26) was provided by K.S.E. Cheah (Kong et al.,
1993). Mouse type IIA procollagen cDNA (exon 2) was from L.J. Sandell
(Metsaranta et al., 1991).
 
In Situ Hybridization
 
Digoxigenin-11-UTPÐlabeled single-strand RNA probes were prepared
using a DIG RNA labeling kit (Boehringer Mannheim) according to the
manufacturerÕs instructions. cDNAs described above were used to gener-
ate antisense and sense probes. Hybridization was performed as described
previously (Hirota et al., 1992). In brief, after deparaffinization, the sec-
tions were treated with 10 
 
m
 
g/ml of proteinase K for 15 min at room tem-
perature, and subjected to 0.2 N HCl to inactivate endogenous alkaline
phosphatase. Hybridization was performed at 50
 
8
 
C in 50% formamide,
and washes were carried out at a stringency of 2
 
3
 
 SSC containing 50%
formamide at 55
 
8
 
C. Then, the slides were subjected to 10 
 
m
 
g/ml of RNase
A in TNE (10 mM Tris-HCl, pH 8.0, 500 mM NaCl, 1 mM EDTA) at 37
 
8
 
C
for 30 min for digestion of nonhybridized transcripts, and washed. A Ge-
nius Detection System (Boehringer Mannheim) according to the manu-
facturerÕs instructions was used to detect signals.
 
Northern Hybridization
 
Total RNA was extracted from the limb buds of 14.5-d postcoitus (d.p.c.)
transgenic and normal embryos using the RNeasy Mini Kit (Qiagen), frac-
tionated by electrophoresis through a formaldehyde agarose gel, and
transferred into Nytran membrane (Schleicher & Schuell). cDNAs were
labeled with [
 
32
 
P]dCTP using the Prime-it II kit (Stratagene). The mem-
branes were hybridized with 
 
32
 
P-labeled CDMP-1 cDNA at 42
 
8
 
C in 50%
formamide, washed first at room temperature in 1
 
3
 
 SSC and 0.1% SDS
and then at 60
 
8
 
C in 0.1
 
3
 
 SSC and 0.1% SDS, and exposed to autoradiog-
raphy film. The filters were rehybridized with 
 
32
 
P-labeled probes for
mouse 
 
a
 
2(XI) collagen, 
 
a
 
1(X) collagen,
 
 Ihh
 
, 
 
PTHrP
 
, and PTH/PTHrP re-
ceptor.
 
Immunohistochemical Staining
 
Cryostat sections were fixed with acetone. Then they were treated by the
primary polyclonal antibody to CDMP-1 raised in rabbits (Chang et al.,
1994), washed with PBS, and incubated with the secondary antibody
(FITC-labeled antibodies; Chemicon).
 
Results
 
Creation of Transgenic Mice Expressing
CDMP-1 in Cartilage
 
Since the expression levels of recombinant CDMP-1 may
affect the phenotype of transgenic mice, we prepared
three different expression vectors derived from the regula-
tory regions of cartilage-specific genes for 
 
a
 
1(II) and
 
a
 
2(XI) collagen chains to obtain different expression lev-
els of recombinant CDMP-1 in transgenic mice. The first
construct was CDMP-1 cDNA linked to the 742-bp 
 
a
 
2(XI)
collagen promoter and intron (742-
 
CDMP1
 
-Int), the sec-
ond was the CDMP-1 cDNA linked to the 
 
a
 
2(XI) collagen
promoter without intron (742-
 
CDMP1
 
), and the third was
the CDMP-1 cDNA linked to 
 
a
 
1(II) collagen promoter
with intron (
 
Col2a1-CDMP1
 
) (Fig. 1 A).
The linearized constructs were microinjected into fertil-
ized eggs and generation zero (G
 
0
 
) embryos were col-
lected at 11.5Ð19.5 d.p.c. (Table I). For the 742-
 
CDMP1
 
construct, 27 embryos were collected of which 8 were
transgenic (29%). For the 742-
 
CDMP1
 
-Int construct, 24 of
the 86 embryos were transgenic (28%). Only one trans-
genic mouse was obtained out of 32 collected embryos for
the 
 
Col2a1-CDMP1
 
 construct (0.3%). In total, 27 out of the
33 transgenic embryos displayed detectable phenotypes
with abnormalities restricted to the skeletal tissues. The
remaining transgenic mice did not have a phenotypic ab-
normality and did not have detectable levels of recombi-
nant CDMP-1 mRNA or protein. Two transgenic mice,
one with 742-
 
CDMP1
 
 and the other with 
 
Col2a1-CDMP1
 
,
were born but died shortly after birth. Both showed a
chondrodysplasia-like phenotype.
 
Gross Skeletal Analysis of CDMP-1 Transgenic Mice
 
At 14.5 d.p.c., two 742-
 
CDMP1
 
 transgenic G
 
0
 
 embryos
were identified due to their large size, i.e., average size of
crown-rump length was 10% larger than that of normal lit-
termates. Anatomical and histological examination of the
transgenic mice revealed no obvious abnormalities in tis-
sues other than skeleton (data not shown). Alcian blue
staining of cartilage showed that the entire cartilaginous
skeleton was enlarged and thickened when compared with
normal mice (Fig. 1, B and C). In contrast, nine 742-
 
CDMP1-
 
Int transgenic G
 
0
 
 embryos were identified with
dwarfism, i.e., average size of crown-rump length was 20%
smaller than that of normal littermates, and kyphotic pos-
ture at 14.5 d.p.c. However, the paws were disproportion-
ally large. The cartilaginous skeleton of 742-
 
CDMP1-
 
Int
transgenic mice was much thicker than that of normal
mice and was similar to 742-
 
CDMP1
 
 transgenic mice (Fig.
1, B and D). The transgenic mouse with
 
 Col2a1-CDMP1
 
showed dwarfism and had profound abnormalities in the
skeletal components at 19.5 d.p.c. Dark-field pictures of
the skeleton stained with alcian blue showed that the
 
Col2a1-CDMP1
 
 transgenic mouse had much thicker skel-
etal components than normal mouse (Fig. 1, H and I).
Most of the phenotypic characteristics in skeletal thick-
ness were maintained in all transgenic mice at 16.5 d.p.c.
(Fig. 1, EÐG). In 742-
 
CDMP1-
 
Int transgenic mice, in addi-
tion to kyphotic posture, skeletal components were so
thick that the intercostal space was almost eliminated in
the rib cage. At this stage, ossification is active and was vi-
sualized with alizarin red S staining in addition to alcian
 
Table I. Production Frequency of Transgenic Mice
 
Transgene construct
Stage of
sacrifice
Number
of pups
obtained
Number of
transgenic
mice
Number of
transgenic mice
with phenotype*
 
d.p.c.
 
742-
 
CDMP1
 
14.5 12 3 2
16.5 13 4 3
19.5 2 1 1
 
à
 
742-
 
CDMP1-
 
Int 11.5 9 3 3
12.5 12 4 3
14.5 19 5 4
16.5 9 3 2
 
Col2a1
 
-
 
CDMP1
 
14.5 17 0 0
15.5 1 0 0
16.5 4 0 0
18.5 6 0 0
19.5 4 1 1
 
à
 
*Abnormalities were predominantly restricted to the skeleton.
 
à
 
Mice died shortly after birth. 
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blue cartilage staining. As can be seen in the metatarsal,
ossification in transgenic mice started at normal develop-
mental stage (Fig. 1, EÐG, arrowheads). However, endo-
chondral ossification in the cranial region was significantly
delayed (Fig. 1, EÐG).
In the transgenic limbs, the distal components, such as
carpals, metacarpals, and phalanges, were more affected
and enlarged than the proximal components (Fig. 2, AÐC)
at 16.5 d.p.c., i.e., average size of the third phalange thick-
ness was 70% larger in 742-
 
CDMP1
 
 transgenic mice
and 150% larger in 742-
 
CDMP1-
 
Int transgenic mice
than that of normal littermates. All abnormal 742-
 
CDMP1-
 
Int transgenic mice had fused joints, whereas 742-
 
CDMP1
transgenic mice did not. The humerus, radius, and ulna of
the 742-CDMP1-Int transgenic mice were united by bone.
In the Col2a1-CDMP1 transgenic mouse at 19.5 d.p.c.,
joints were completely fused by the bone (Fig. 2, D and E).
The ribs of 742-CDMP1 and 742-CDMP1-Int transgenic
mice at 16.5 d.p.c. were thicker than normal, i.e., diameter
of the 742-CDMP1 and 742-CDMP1-Int transgenic ribs
was two to three times thicker than that of normal lit-
termates (Fig. 2, FÐH). The Col2a1-CDMP1 transgenic
mouse at 19.5 d.p.c. also had thick ribs, i.e., diameter of the
Col2a1-CDMP1 transgenic ribs was at least four times
Figure 1. Transgene constructs and
skeletal abnormalities of CDMP-1
transgenic mice. (A) Diagrams of the
DNA constructs used to generate
Col11a2-CDMP1 (left) and Col2a1-
CDMP1 (right) transgenic mice. The
gene structures of Col11a2 and Col2a1
are shown at the top of each panel.
Boxes indicate the coding regions and
solid lines denote noncoding se-
quences. The transgenes are shown be-
low the genomic map. Brackets indi-
cate intron cassettes. (BÐI) Skeletons
of CDMP-1 transgenic mice. Entire
skeletons of normal (B and E), 742-
CDMP1 transgenic (C and F), and 742-
CDMP1-Int transgenic (D and G) em-
bryos were stained with alcian blue
(BÐD) and alcian blue plus alizarin red
(EÐG). The rib cages of a normal
mouse (H) and a Col2a1-CDMP1
transgenic mouse (I) were stained with
alcian blue and shown in dark field.
(BÐD) Embryos at 14.5 d.p.c.; (EÐG)
16.5 d.p.c.; (H and I), 19.5 d.p.c. 742-
CDMP1 transgenic mice were large,
whereas 742-CDMP1-Int and Col2a1-
CDMP1 transgenic mice were small.
The skeletal components were thick in
all transgenic mice. In 742-CDMP1-Int
and  Col2a1  transgenic mice, the ribs
were so thick that intercostal spaces
were almost eliminated. Ossification
had just started at metatarsals in nor-
mal and transgenic mice (EÐG, arrow-
heads). Scale bars, 2 mm.Tsumaki et al. The Role of CDMP-1 in Skeletal Development 165
thicker than that of normal littermates (Fig. 2, I and J).
The degree of the thickness of the skeleton and the en-
largement of the paws in 742-CDMP1-Int transgenic mice
was consistently more severe than those of 742-CDMP1
transgenic mice. Although stages were different, the de-
gree of deformity in Col2a1-CDMP1 transgenic mouse ap-
peared to be more severe than that of 742-CDMP1-Int
transgenic mice.
Gene Expression in CDMP-1 Transgenic Mice
Northern analysis demonstrated expression of CDMP-1 in
the limb buds in transgenic mice (Fig. 3 A, top). Recombi-
nant CDMP1 mRNA was z3 kb in size and slightly larger
than endogenous Gdf5/CDMP1 mRNA due to the length
differences in both the 59 and 39 untranslated regions. Ex-
pression levels of the transgene in the 742-CDMP1-Int
transgenic mice were about twofold higher than those in
the 742-CDMP1 transgenic mice (Fig. 3 A, lanes 2 and 3).
A low level of endogenous Gdf5/CDMP1 mRNA was
found in normal mice (Fig. 3 A, lane 1, arrow). The ex-
pression levels of mRNAs for Indian hedgehog (Ihh) and
type X collagen a1 chain (Col10a1) genes, markers for
prehypertrophic and hypertrophic chondrocytes, respec-
tively, were elevated in 742-CDMP1 and 742-CDMP1-Int
transgenic mice.
In situ hybridization analysis indicated that recombinant
CDMP-1 mRNA was localized in resting and proliferative
chondrocytes of primordial cartilage in the forelimbs of
14.5 d.p.c. and ribs of 16.5 d.p.c. transgenic mice (Fig. 3,
Figure 2. Examination of the skeleton
of the forelimbs and ribs of CDMP-1
transgenic mice. (AÐC) Skeletal com-
ponents of the forelimb at 16.5 d.p.c.
stained with alcian blue and alizarin
red. In the 742-CDMP1 (B) and 742-
CDMP1-Int (C) transgenic mice, the
distal components (brackets), such as
the carpals, metacarpals, and phalan-
ges, were larger than those of normal
mice (A), whereas the proximal com-
ponent such as the scapula of the trans-
genic mice was not so enlarged. The
extent of deformity of 742-CDMP1-Int
transgenic mice was more severe than
that of 742-CDMP1 transgenic mice.
(D and E) Skeletal components of the
forelimb at 19.5 d.p.c. stained with al-
cian blue shown in the dark field. In
the Col2a1-CDMP1 transgenic mouse
(E), the skeleton of the paws was much
enlarged compared with the normal
mouse (D). Note the difference in the
scale between D and E. 742-CDMP1-
Int and Col2a1-CDMP1 transgenic
mice had fused joints, whereas 742-
CDMP1 transgenic mice did not. The
humerus, radius, and ulna of 742-
CDMP1-Int and Col2a1-CDMP1
transgenic mice were united by bone.
(FÐH) Ribs at 16.5 d.p.c. stained with
alcian blue and alizarin red. The ribs of
742-CDMP1 (G) and 742-CDMP1-Int
(H) transgenic mice were thicker than
those of normal mice (F) at 16.5 d.p.c.
(I and J) Ribs at 19.5 d.p.c. stained
with alcian blue shown in the dark
field. The Col2a1-CDMP1 transgenic
mouse (I) also had much thicker ribs
than normal mice (J). The degree of
the thickness of the skeleton and the
enlargement of the paw in 742-
CDMP1-Int transgenic mice were con-
sistently more severe than those of
742-CDMP1 transgenic mice. Al-
though stages were different, the degree of deformity in the Col2a1-CDMP1 transgenic mouse appeared to be more severe than that of
742-CDMP1-Int transgenic mice. s, scapula; h, humerus; r, radius; u, ulna. Brackets in AÐE indicate skeletal components of paws includ-
ing carpals, metacarpals, and phalanges. Scale bars, 1 mm.The Journal of Cell Biology, Volume 144, 1999 166
B and C). The CDMP-1 expression levels in the 742-
CDMP1-Int transgenic mice were higher than those in the
742-CDMP1  transgenic mice, similar to what was ob-
served by Northern analysis. Expression patterns of the
transgene were almost identical to those of the a2(XI) col-
lagen gene in the rib (Fig. 3 C) and limb (Fig. 4 B, second
and third rows). Immunohistochemical analysis using an
antiÐCDMP-1 polyclonal antibody showed that cartilage
in the transgenic mice expressed a higher level of CDMP-1
compared with normal mice, suggesting that the transgene
mRNA was translated (Fig. 3 D). In situ hybridization
showed that CDMP1 mRNA was expressed in the carti-
lage in a 19.5 d.p.c. Col2a1-CDMP1 transgenic mouse
(data not shown). No expression of endogenous Gdf5/
CDMP1 mRNA was detected in normal mice at this stage
(data not shown).
Endochondral Bone Formation of CDMP-1
Transgenic Mice
The most striking change in the cartilage of 742-CDMP1-
Int transgenic mice was an enlargement of the hyper-
Figure 3. Gene expression of CDMP-1
transgenic mice. (A) Northern blot
analysis using total RNAs extracted
from limb buds of normal (lane 1), 742-
CDMP1 (lane 2), and 742-CDMP1-Int
(lane 3) transgenic mice at 14.5 d.p.c.
For each lane, 20 mg RNA was loaded,
transferred to the nylon membrane,
and hybridized with corresponding
probes indicated at the left of the pan-
els. The bottom panel shows the ethid-
ium bromideÐstained gel before trans-
fer. Transgenic CDMP-1 mRNA was
expressed strongly compared with en-
dogenous  Gdf5/CDMP1 mRNA (ar-
rowhead). The expression levels of Ihh
and  Col10a1 mRNAs, markers for
chondrocyte differentiation, were ele-
vated in the transgenic mice. (B) Dis-
tribution of CDMP1 mRNA in the
forelimb of normal (left), 742-CDMP1
transgenic (middle), and 742-CDMP1-
Int transgenic (right) mice at 14.5 d.p.c.
(Top) Staining with hematoxylin and
eosin. (Bottom) In situ hybridization
of semiserial sections using CDMP1
antisense probe. In the transgenic
mice,  CDMP-1 mRNA was distributed
in proliferating chondrocytes, but not
in hypertrophic chondrocytes. Note
that the height of the hypertrophic
zone was increased in transgenic mice.
(C) CDMP1 and Col11a2 expression in
the rib of normal (left) and 742-
CDMP1-Int transgenic (right) mice at
16.5 d.p.c. (Top) Staining with hema-
toxylin and eosin. (Middle) In situ
hybridization of CDMP1 antisense
probe of semiserial sections. (Bottom)
Col11a2 antisense probe. In the trans-
genic mice, CDMP-1 mRNA was dis-
tributed in proliferating chondrocytes,
but not in hypertrophic chondrocytes.
The localization of CDMP-1 mRNA
was identical to that of Col11a2
mRNA. (D) Immunohistochemical
analysis of the primordial cartilage of
the tarsals of normal (left) and 742-
CDMP1-Int transgenic (right) mice at
14.5 d.p.c. (Top) Staining with hema-
toxylin and eosin. (Bottom) Immunostaining of antiÐCDMP-1 polyclonal antibody showed transgenic cartilage contained a significant
amount of CDMP-1. r, resting chondrocytes; p, proliferating chondrocytes; h, hypertrophic chondrocytes. Scale bars, B, 500 mm; C, 200
mm; D, 50 mm.Tsumaki et al. The Role of CDMP-1 in Skeletal Development 167
trophic zone (Fig. 4, A and B, top row). In the transgenic
mice, the carpals and the distal part of the radius and ulna
were completely fused and underwent endochondral bone
formation as a single component (Fig. 4 B, top row). 742-
CDMP1 transgenic mice also showed an enlarged hyper-
trophic zone compared with normal mice, but to a lesser
extent than the 742-CDMP1-Int transgenic mice (Fig. 3
B). For further identification of chondrocyte types at spe-
cific stages of differentiation, we performed in situ hybrid-
ization using specific marker genes as probes (Fig. 4 B).
Type XI collagen and type X collagen probes were used as
markers for proliferating and hypertrophic zones, respec-
tively. Indian hedgehog (Ihh) was used as a marker for the
prehypertrophic zone located between these two zones.
The areas expressing Ihh and type X collagen mRNAs
were remarkably enlarged in 742-CDMP1-Int transgenic
mice by 12- and 6-fold, respectively, indicating both prehy-
pertrophic and hypertrophic zones were expanded com-
pared with normal cartilage. Northern analysis of total
RNA from 14.5 d.p.c. limb buds also showed significant el-
evation of the expression levels of Ihh and type X collagen
mRNAs in both 742-CDMP1 and 742-CDMP1-Int trans-
genic mice (Fig. 3 A).
Mesenchymal Condensation and Chondroprogenitor 
Cells of CDMP-1 Transgenic Mice
During skeletal development, recombinant CDMP-1 ex-
pression was found in transgenic mice at 12.5 d.p.c., when
mesenchymal cells aggregated to form condensation (data
not shown). At this stage, mesenchymal condensations in
the forelimb bud of the transgenic mice were already con-
siderably expanded as compared with the wild type (Fig. 5,
A and B) and were composed of increased numbers of
Figure 4. Altered endochondral bone
formation in Col11a2-CDMP1 trans-
genic mice. (A) Histological sections of
the humerus of normal (left) and 742-
CDMP1-Int transgenic mice (right) at
14.5 d.p.c. (Top) Staining with Safranin
O-fast green-iron hematoxylin of en-
tire humerus. The transgenic mice
(right) had the increased height of a
zone of hypertrophic chondrocytes (h)
compared to normal mice (left). In the
transgenic mice, the primordial carti-
lage was wide and elbow joints were
fused. (Bottom) Magnifications of the
boxed regions of the distal part of the
humerus in the top panels. The height
of zones of proliferating chondrocytes
was reduced in the transgenic mice.
Note that arrays of chondrocytes at the
bottom (asterisk) were different from
those of chondrocytes located above in
the transgenic mice. They were chon-
drocytes of the proximal part of the
ulna. Hematoxylin and eosin staining.
(B) Spatial expression of marker genes
for endochondral bone formation in
the forelimb of normal (left) and 742-
CDMP1-Int transgenic (right) mice at
16.5 d.p.c. (Top row) Staining with Saf-
ranin O-fast green-iron hematoxylin.
The skeletal components consist of
proliferating and hypertrophic zones of
chondrocytes and bone. In the trans-
genic mice, the carpals and distal part
of the radius and ulna were completely
fused and underwent endochondral
bone formation as a single component.
Semiserial sections were hybridized
with cRNA probes of corresponding
genes indicated on the left. Areas ex-
pressing Ihh (fourth row) and type X
collagen (fifth row) mRNAs were re-
markably enlarged in transgenic mice.
r, resting chondrocytes; p, proliferating
chondrocytes; h, hypertrophic chon-
drocytes. Scale bars, 100 mm.The Journal of Cell Biology, Volume 144, 1999 168
mesenchymal cells. It has been demonstrated that the
number of AgNORs (nucleolar organizer regionÐassoci-
ated proteins) is indicative of proliferative cellular activ-
ity correlating well with proliferating nuclear cell antigen
(PCNA) expression (Crocker and Nar, 1987; Leek et al.,
1991; Heinisch and Wozel, 1995; Nagano et al., 1995).
Therefore, we analyzed AgNORs by silver staining to ex-
amine proliferative cell populations in mesenchymal con-
densations as markers of cell proliferative activity. In
normal mice, cells in the peripheral region of the conden-
sation were characterized by a flattened shape and con-
tained an increasing number of AgNORs staining per cell
(Fig. 5 C, arrowheads) whereas cells in the central region
showed a round shape (Fig. 5 C). The number of periph-
eral cells with these characteristics in the condensation of
the transgenic mice was much higher than that of the nor-
mal mice (Fig. 5 D). Thus, the expanded mesenchymal
condensation in the transgenic mice consisted of more
proliferative cell populations than the normal mice. At
14.5 d.p.c., similar expansion of the proliferative cell
population was also observed in the perichondrium sur-
rounding epiphyseal cartilage of 742-CDMP1-Int trans-
genic mice. The perichondrium of the transgenic mice was
thicker and composed of more multiple cell layers than in
the normal mice (Fig. 5, E and F).
The increased number of chondroprogenitor cells in
742-CDMP1-Int transgenic mice was also confirmed by in
situ hybridization with a probe for collagen type IIA
mRNA (Fig. 6). Two forms of type II procollagen are gen-
erated by alternative splicing of the exon 2 sequence
(Ryan and Sandell, 1990) and the longer form (type IIA)
containing the exon 2 sequence expressed predominantly
by chondroprogenitor cells but not proliferative chondro-
cytes. Therefore, we analyzed the expression of type IIA
mRNA as a marker for cells committed for a chondrocytic
lineage (Sandell et al., 1994). At 13.5 d.p.c., cartilage an-
lages of phalanges, carpals, radius, and ulna were recogniz-
able in the forelimb (Fig. 6 A). In CDMP-1 transgenic
mice, these components were expanded and fused, form-
ing a single anlage (Fig. 6 B). The expression of type IIA
mRNA was more profound in cells surrounding the trans-
genic cartilage than the wild type, suggesting the increased
Figure 5. Mesenchymal condensation and perichondrium of
CDMP-1 transgenic mice. (A, C, and E) Normal mice. (B, D, and
F) 742-CDMP1-Int transgenic mice. (A and B) Axial sections of
mesenchymal condensation in the forelimb bud at 12.5 d.p.c.
Mesenchymal condensation was already expanded in transgenic
mice. Hematoxylin and eosin staining. (C and D) AgNORs in
mesenchyme of boxed portions in top panels. In normal mice
(C), peripheral cells (arrowheads) located between the central
part of mesenchymal condensation (c) and surrounding mesen-
chymal cells (m) contained large number of AgNORs, indicative
of proliferative activities. In transgenic mice (D), the number of
peripheral cells was increased and formed multiple layers. (E and
F) Perichondrium (arrows) of epiphyseal cartilage (e) of the dis-
tal ulna at 14.5 d.p.c. Compared with normal mice, transgenic
mice showed thick perichondrium consisting of multiple cell lay-
ers. Scale bars, 50 mm.
Figure 6. Expression of type IIA collagen mRNA in the forelimb
at 13.5 d.p.c. (A and B) Hematoxylin and eosin staining. In the
transgenic mice, the phalanges, carpals, and distal part of the ra-
dius and ulna were completely fused and formed single thick car-
tilage anlage. (CÐF) In situ hybridization with the antisense type
IIA collagen mRNA probe of semiserial sections (C and D) and
magnification of the boxed regions (E and F). Type IIA mRNA-
positive cells surrounded the cartilage anlage in transgenic mice,
whereas only faint signals were detected in normal mice. Scale
bars, AÐD, 500 mm; E and F, 100 mm.Tsumaki et al. The Role of CDMP-1 in Skeletal Development 169
number of chondroprogenitor cells in CDMP-1 transgenic
cartilage (Fig. 6, CÐF).
Abnormalities in the Vertebral Bodies of CDMP-1 
Transgenic Mice
There is a striking difference in the formation of vertebral
bodies between transgenic mice with 742-CDMP1 and
742-CDMP1-Int. In 742-CDMP1 transgenic mice, verte-
bral bodies were expanded (Fig. 7, B, E, and H). On the
other hand, vertebral bodies were absent in 742-CDMP1-
Int transgenic mice as seen in skeletal staining of the spinal
column at 14.5 and 16.5 d.p.c. (Fig. 7, C, F, and I). The
Col2a1-CDMP1 transgenic mouse also resembled the 742-
CDMP1-Int transgenic mice (data not shown). We per-
formed histological analysis and in situ hybridization at
earlier stages to access the role of CDMP-1 in vertebral
body malformation. CDMP1 mRNA was expressed spe-
cifically in the notochord of the 742-CDMP1-Int trans-
genic mice at 11.5 d.p.c. when chondrogenesis had not yet
occurred, whereas CDMP1 mRNA was not expressed in
the normal mice, agreeing with previous findings (Storm
et al., 1994) (Fig. 8, C and D). Sonic hedgehog ( Shh)
mRNA was expressed in the notochord in both normal
mice and 742-CDMP1-Int transgenic mice (Fig. 8, E and
F). Since the vertebral bodies develop from Pax1-express-
ing sclerotome cells (Deutsch et al., 1988), we examined
expression of Pax1 during development. Development of
the axial structure progresses in a cranio-caudal direction.
Therefore, axial sections at the caudal level represent an
earlier stage of development than those at the cranial level
of the embryo. At the caudal level at 11.5 d.p.c., ventral
parts of sclerotome consisted of Pax1-positive cells in both
normal and transgenic mice (Fig. 8, G and H). At the cra-
nial level at 11.5 d.p.c., Pax1-positive cells were migrating
from the somite to the notochord in normal mice, whereas
in 742-CDMP1-Int transgenic mice, Pax1-positive cells re-
mained near the somite (Fig. 8, I and J). At 12.5 d.p.c.,
Pax1-expressing cells were localized around the notochord
and appeared to be forming the primordial cartilage of
vertebral bodies in normal mice (Fig. 8 K). In contrast,
there were no signals of Pax1 expression near the noto-
chord of 742-CDMP1-Int transgenic mice (Fig. 8 L).
Histological sections of 12.5 d.p.c. embryos showed that
mesenchymal cells were condensing around the notochord
of normal mice (Fig. 8, M and O). In contrast, mesenchy-
mal cells around the notochord of 742-CDMP1-Int trans-
genic mice were disorganized (Fig. 8, N and P). In addi-
tion, the sheath of the notochord was not clearly seen in
the transgenic mice (Fig. 8 P). These results suggest that
Figure 7. Spinal columns stained with
alcian blue and alizarin red. Normal
(A, D, and G), 742-CDMP1 transgenic
(B, E, and H), and 742-CDMP1-Int
transgenic (C, F, and I) mice. (AÐF)
The spinal columns with the ribs were
viewed from the ventral side at 14.5
d.p.c. (AÐC) and at 16.5 d.p.c. (DÐF).
742-CDMP1 transgenic mice had thick
skeletal components including the ver-
tebral bodies (v), neural arches (na),
and ribs (r) (B and E). In 742-CDMP1-
Int transgenic mice, the vertebral bod-
ies were absent (C and F). (GÐI) Axial
view of the third lumber vertebrae of
mice at 16.5 d.p.c. The vertebral body
was enlarged in 742-CDMP1 trans-
genic mice (H) and absent in 742-
CDMP1-Int transgenic mice (I). v, ver-
tebral bodies; na, neural arch; r, rib.
Scale bars, 1 mm.The Journal of Cell Biology, Volume 144, 1999 170
CDMP-1 expression in the notochord blocks migration of
Pax1-expressing cells from the sclerotome to the noto-
chord and thus blocks the vertebral body formation.
Discussion
We have studied the phenotypic changes in transgenic
mice by targeted expression of CDMP-1 to cartilage to
gain insights into the mechanism of action of BMPs in
skeletal development. The transgenic mice developed ab-
normal phenotypes characteristic of chondrodysplasia and
died before or just after birth. Many of the cartilage ele-
ments in the transgenic mice were thick and enlarged con-
taining reduced height of the proliferating zone and ex-
panded prehypertrophic and hypertrophic zones. The
number of cells within the mesenchymal condensations
and the number of prechondrogenic cells in the transgenic
mice were increased. These results suggest that CDMP-1
enhances the commitment of mesenchymal cells into the
chondrogenic lineage and their differentiation toward hy-
pertrophy. Ectopic expression of CDMP-1 in the noto-
chord before onset of chondrogenesis inhibited mesenchy-
mal cell condensation around the notochord, which led to
failure of vertebral body formation. Although there are
many reports which suggest the important role for BMPs
in chondrogenesis and osteogenesis using primary cells
and progenitor cell lines, our results convincingly show
that CDMP-1 affects skeletal growth and chondrocyte
maturation in vivo.
Skeletal Abnormalities of CDMP-1 Transgenic Mice
We used three different promoter/enhancer sequences
to induce various levels of expression of recombinant
CDMP-1 in the developing skeleton. In situ hybridization
and immunostaining revealed that the transgene was tran-
scribed and produced CDMP-1 protein in cartilage. The
chondrodysplasia-like phenotypes of the transgenic mice
were consistent among individual founder mice for each
construct, confirming that the abnormal phenotypes were
caused by the expression of recombinant CDMP-1. The
three different expression vectors generated transgenic
mice with distinct phenotypes, though all showed charac-
teristics for chondrodysplasia. The differences were found
in body size, joint formation, and the extent of deformity
of the skeleton and appear to be caused by different ex-
pression levels of recombinant CDMP-1. The Col2a1-
CDMP1 construct produced a very severe phenotype with
a low production frequency (0.3%) of transgenic mice. It is
Figure 8. Histology and expression analysis of spine of 742-
CDMP1-Int transgenic mice. (AÐH) Axial semiserial sections at
caudal level (in tail region) of the spine of normal (A, C, E, and
G) and 742-CDMP1-Int transgenic (B, D, F, and H) embryos at
11.5 d.p.c. Staining with hematoxylin and eosin (A and B). In situ
hybridization of CDMP1 (C and D), Shh (E and F), and Pax1 (G
and H) antisense probes. In transgenic mice, CDMP-1 mRNA
was localized in the notochord. (I and J) In situ hybridization of
sections at the cranial level (thoracic region) of the spine of nor-
mal (I) and 742-CDMP1-Int transgenic (J) embryos at 11.5 d.p.c.
using Pax1 antisense probe. (KÐN) Axial semiserial sections of
spine in the thoracic region in normal (K and M) and 742-
CDMP1-Int transgenic (L and N) embryos at 12.5 d.p.c. In situ
hybridization of Pax1 (K and L) and staining with hematoxylin
and eosin (M and N). In normal mice, Pax1-expressing sclero-
tome cells migrated toward the notochord to form aggregation as
the developmental stage progressed (G, I, and K). In transgenic
mice, those cells remained laterally (H, J, and L). (O and P) Mag-
nifications of the region around the notochord in M and N, re-
spectively. In 742-CDMP1-Int transgenic mice, mesenchymal
cells around the notochord were disorganized, and the sheath of
the notochord was not clear. Arrowhead, notochord; nt, neural
tube. Scale bars, AÐN, 200 mm; O and P, 50 mm.Tsumaki et al. The Role of CDMP-1 in Skeletal Development 171
likely that most Col2a1-CDMP1 transgenic embryos were
lethal at very early stages of development because the ex-
pression level of CDMP-1 directed by the type II colla-
gen promoter/enhancer was very high. Only one Col2a1-
CDMP1 transgenic mouse survived until birth, probably
because the expression level was incidentally low due to
the site of integration. A major difference between the
742-CDMP1 and 742-CDMP1-Int transgenic mice was in
body size. All 742-CDMP1 mice were larger than the
normal mice, whereas 742-CDMP1-Int mice showed dwarf-
ism. The difference is likely due to the absence of verte-
bral bodies and fusion of joints in 742-CDMP1-Int trans-
genic mice.
Primordial Cartilage
A phenotype common to all of the transgenic mice was the
expansion of the primordial cartilage. The expansion was
more prominent in distal skeletal components, such as the
paws, than in proximal components of the limb. The de-
gree of the expansion seemed to be correlated with the
promoter activities used for transgene constructions. Our
finding of greatly expanded paws in transgenic mice is in-
consistent with the phenotype of GDF5/CDMP1 null mu-
tations in mice and humans which cause shortening of ap-
pendicular skeleton, with prominent reduction in size of
paws or hand and foot skeletal components (Storm et al.,
1994; Thomas et al., 1996). These results strongly suggest
that GDF5/CDMP-1 controls the size of skeletal compo-
nents in the distal part of the limb.
In normal development, GDF5/CDMP-1 is not ex-
pressed in axial skeleton, such as rib and spine, which ac-
counts for the unique chondrodysplasia phenotype of the
mutations in mice and humans with little abnormalities
in the axial skeleton. However, expansion of the ribs in
CDMP-1 transgenic mice indicates that CDMP-1 func-
tions effectively in the axial skeleton. This activity is prob-
ably mediated by BMP receptors which are expressed in
axial skeleton as well as in the limb skeleton (Dewulf et al.,
1995). These results suggest that CDMP-1 can effectively
transmit cellular signaling in tissues where other BMPs
normally function in skeletal formation. Members of the
BMP family apparently share common functions. How-
ever, unique expression patterns and affinity to the spe-
cific receptors play an important role in regulating the pat-
terning and formation of different skeletal components.
Our results clearly support the notion that the spatial reg-
ulation of BMP expression is important for controlling the
size, number, and shape of individual skeletal components
(Kingsley, 1994).
Cellular signaling by BMPs is mediated by two types of
serine/threonine kinase receptors, type I (BMPR-I) and
type II (BMPR-II). There are two type I receptors, type
IA (BMPR-IA) and IB (BMPR-IB). It has been reported
that CDMP-1/GDF5 binds to BMPR-IB and BMPR-II,
but not to BMPR-IA (Nishitoh et al., 1996). Recently, Zou
et al. (1997) showed that overexpression of constitutively
activated BMPR-IB elicited extensive mesenchymal con-
densation and expansion of the primordial cartilage in
chick limb buds by means of retrovirus vectors. However,
expression of constitutively activated BMPR-IA delayed
chondrocyte differentiation (Zou et al., 1997). Stimulation
of mesenchymal condensation and subsequent expansion
of the primordial cartilage in CDMP-1 transgenic mice
suggest that recombinant CDMP-1 may bind to BMPR-IB
and induces intracellular signaling for the expansion of
cartilage. Promotion of chondrocyte differentiation also
suggests that recombinant CDMP-1 may not bind effec-
tively to BMPR-IA even if it was overexpressed in trans-
genic mice. Thus, our findings are inconsistent with those
previous reports.
During the skeletal development of CDMP-1 transgenic
mice, cell expansion was already apparent in mesenchymal
condensations. At this stage, expansion was primarily
caused by the increased number of cells organizing con-
densation. At 13.5 d.p.c. when cartilage anlages are recog-
nizable, transgenic cartilage was surrounded by type IIA
mRNA-positive cells, whereas the signal for type IIA
mRNA in normal mice was much weaker. Because type
IIA mRNA is a good marker for chondroprogenitor cells
(Sandell et al., 1994), cells surrounding transgenic cartilage
are likely representing mesenchymal cells committed to a
chondrocytic lineage. Taken together with the enlarge-
ment of mesenchymal condensation, the increased num-
bers of chondroprogenitor cells in transgenic mice suggest
that CDMP-1 enhanced recruitment of mesenchymal cells
to the chondrocytic lineage, contributing to the formation
of thicker transgenic cartilage.
Promotion of Chondrocytic Differentiation
A striking feature in the cartilage common to all of the
transgenic mice was the increased size of prehypertrophic
and hypertrophic zones accompanied with the decreased
size of the proliferating chondrocyte zone. Endochondral
bone formation is initiated when chondrocytes in the cen-
ter of primordial cartilage proliferate to expand cell popu-
lation and differentiate into hypertrophic chondrocytes.
Hypertrophic chondrocytes eventually degenerate and die
and are replaced by osteoblasts to form bone. This process
radiates outward with the formation of the growth plates
at both ends of primordial cartilage. These temporal
events are represented spatially by zones for proliferative
and hypertrophic chondrocytes (Fig. 4 A, second row, and
Fig. 9) (Horton, 1993). The reduction in the height of the
proliferating zone in 724-CDMP1-Int transgenic mice is
likely due to accelerated cell differentiation into hyper-
trophic chondrocytes (Fig. 9). It is conceivable that en-
hanced differentiation of these cells into hypertrophic
chondrocytes could result in the increased height of zone
of hypertrophy in transgenic mice. In situ hybridization
with the Ihh and type X collagen genes, markers for prehy-
pertrophic and hypertrophic chondrocytes, showed the en-
largement of the prehypertrophic and hypertrophic zones.
These results suggest that CDMP-1 expression promotes
differentiation of chondrocytes to hypertrophy. Recently,
it has been reported that BMP signaling mediated by
BMPR-II is necessary for the maintenance of the differen-
tiation phenotype (Enomoto-Iwamoto et al., 1998). In ad-
dition, BMP responsive elements were found in the pro-
moter region of the type X collagen gene (Volk et al.,
1998). In transgenic mice, CDMP-1 could bind to the type
II receptor and activate a BMP signaling to promote dif-
ferentiation of chondrocytes.The Journal of Cell Biology, Volume 144, 1999 172
Ossification in the transgenic mice apparently initiated
at the normal developmental stages except the cranial
bone. These results suggest different mechanisms of bone
formation in these tissues.
Vertebral Bodies
Formation of the primordial cartilage of vertebral bodies
is unique and complex because precursor cells migrate
from remote places to form aggregation. Sclerotome cells
located lateral to the neural tube migrate toward the noto-
chord ventral to the neural tube to form primordial carti-
lage of vertebral bodies around the notochord (Christ and
Wilting, 1992). This migration is believed to be guided by
morphogens such as sonic hedgehog (Shh) secreted from
the notochord (Fan and Tessier-Lavigne, 1994; Johnson
et al., 1994). Intensive studies have shown that several
BMPs are expressed in the dorsal part of the neural tube
and surface ectoderm. These BMPs induce dorsal cell
types in neural tube (Liem et al., 1995) and spinal column
(Monsoro-Burq et al., 1996) and are believed to antago-
nize the ventralization signals from the notochord. In 742-
CDMP1-Int transgenic mice, CDMP1 was expressed in
the notochord before the onset of chondrogenesis. Expres-
sion of Shh in the notochord was found in the transgenic
mice similar to that seen in normal mice, and Pax1 expres-
sion was induced in the sclerotome normally. However,
Pax1-expressing sclerotome cells did not migrate toward
the notochord, resulting in formation of the Pax1-negative
region with a diameter of 200 mm in the transgenic mice.
Because CDMP-1 binds and signals through receptor com-
plexes used by other BMPs which mediate the dorsalizing
signals (Nishitoh et al., 1996), it is tempting to assume that
recombinant CDMP-1 expressed in the notochord of the
transgenic mice antagonizes the ventralizing signals. Inhi-
bition of migration of Pax1-positive cells to the notochord
resulted in the failure of vertebral body formation at later
stages. Abnormal appearance of the notochord suggests
that CDMP-1 might affect the notochord itself as well.
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